Dr Luigi Palombi read law between 1977 and 1981 and economics between 1982 and 1985 at the University of Adelaide. He practiced law in Australia between 1982 and 1997, specialising in patent law and biotechnology. He led the Australian litigation team that challenged the validity of a patent which claimed isolated hepatitis C virus nucleotides and polypeptides as inventions. Having led several international patent litigation teams involving litigation in the United States as well as in the UK and Europe (including the European Patent Office), between 1997 and 2001 he advised various organisations around the world with regard to human health, biotechnology and gene related patents. Between 2001 and 2004 he undertook his PhD candidature (The Patenting of Biological Materials in the Context of TRIPS) at the University of New South Wales. After he was awarded his doctorate in 2005, he consulted to Minter Ellison, one of Australia's leading law firms, in biotechnology patents. Since 2006 he has headed the Genetic Sequence Right Project at the Australian National University and 2007 he and his colleague, Prof Peter Drahos, of the Regulatory Institutions Network at The Australian National University were awarded a three year Australian Research Council Discovery Project Grant entitled The Sustainable Use of Australia's Biodiversity: Transfer of Traditional Knowledge and Intellectual Property. He has delivered invited papers and lectures in patent law at international legal conferences, meetings and to expert panels. He has made submissions to many inquiries into intellectual property and given evidence before an Australian Senate Committee investigating the impact of gene patents. His has written on various aspects of patent law and gene patents.